OmniAb Inc.

0.40
0.05 (14.29%)
At close: Jan 30, 2025, 11:10 AM
0.40
0.00%
Pre-market Jan 30, 2025, 11:10 AM EST
undefined%
Bid 0.1
Market Cap 406.71M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 2147.48
Volume 160
Avg. Volume (20D) 0
Open 0.40
Previous Close 0.35
Day's Range 0.40 - 0.40
52-Week Range 0.40 - 0.40
Beta undefined

About OABIW

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been geneti...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 106
Stock Exchange NASDAQ
Ticker Symbol OABIW
No News article available yet